Charter Oak Capital Management, LLC Moderna, Inc. Transaction History

Charter Oak Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2022	SELL	$117.13 - $176.59 $819 - $1,236	-7 Reduced 12.5%	49 $7,000
Q1 2022 May 05, 2022	BUY	$126.46 - $235.05 $1,264 - $2,350	10 Added 21.74%	56 $9,000
Q4 2021 Feb 09, 2022	BUY	$225.82 - $368.51 $1,806 - $2,948	8 Added 21.05%	46 $12,000
Q3 2021 Nov 08, 2021	BUY	$221.9 - $484.47 $221 - $484	1 Added 2.7%	38 $15,000
Q2 2021 Jul 29, 2021	SELL	$129.91 - $234.98 $2,468 - $4,464	-19 Reduced 33.93%	37 $9,000
Q1 2021 May 17, 2021	SELL	$109.18 - $185.98 $4,367 - $7,439	-40 Reduced 41.67%	56 $7,000
Q4 2020 Feb 12, 2021	BUY	$65.74 - $169.86 $6,311 - $16,306	96 New	96 $10,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Charter Oak Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Charter Oak Capital Management, LLC with notifications on news.